Singh S, Wright EE Jr, Kwan AY, et al
Injection site reactions such as mild redness, itching, or small lumps are common with GLP-1 receptor agonists

Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other factors, many of which are beyond the Company's control, including but not limited to risks related to research and development activities, scientific and technical challenges, formulation and manufacturing difficulties, clinical study preparation and execution, bioanalytical testing, pharmacokinetic outcomes, safety and tolerability findings, the possibility that preclinical or early-stage results may not be predictive of future clinical results, uncertainties relating to regulatory review and approval processes, intellectual property protection and enforcement risks, reliance on third-party advisors, contract research organizations, manufacturers, development partners and suppliers, competitive technologies, market acceptance, financing availability, and general economic, financial, regulatory, and capital market conditions

Your doctor can make an informed decision about adjusting your GLP-1 protocol to ensure you can appropriately manage its side effects
This medicine works like a natural hormone in your body called GLP-1
We are so excited to bring this new formulation to